The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Specificity, diversity, and regulation in TGF‐β superfamily signaling
Abstract
Transforming growth factor‐β (TGF‐β) superfamily members are multifunctional cell‐cell signaling proteins that play pivotal roles in tissue homeostasis and development of multicellular animals. They mediate their pleiotropic effects from membrane to nucleus through distinct combinations of type I and type II serine/threonine kinase receptors and their downstream effectors, known as Smad proteins. Certain Smads, termed receptor‐regulated Smads, become phosphorylated by activated type I receptors and form heteromeric complexes with a common‐partner Smad4, which translocates into the nucleus to control gene transcription. In addition to these signal transducing Smads, inhibitory Smads have been identified that inhibit the activation of receptor‐regulated Smads. In contrast to the still growing TGF‐β superfamily (with ~30 members in mammals), relatively few type I and type II receptors as well as Smads have been identified. We will focus on recent insights into the molecular mechanisms by which signaling specificity between different TGF‐β superfamily members is achieved and regulated, and how a single family member can elicit a broad scala of biological responses.—Piek, E., Heldin, C.‐H., ten Dijke, P. Specificity, diversity, and regulation in TGF‐β superfamily signaling. FASEB J. 13, 2105–2124 (1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–218 of 218
Processing of the Transforming Growth Factor β Type I and II Receptors
Koli, K. M., & Arteaga, C. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6423 · Cited by 64
Interaction of Transforming Growth Factor β Receptors with Apolipoprotein J/Clusterin
Reddy, K. B., Karode, M. C., Harmony, J. A. K., & Howe, P. H. (1996) · Biochemistry · doi:10.1021/bi951880a · Cited by 64
Distinct Endocytic Responses of Heteromeric and Homomeric Transforming Growth Factor β Receptors
Anders, R. A., Arline, S. L., Doré, J. J. E., & Leof, E. B. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.11.2133 · Cited by 61
Anders, R. A., Doré, J. J. E., Arline, S. L., Garamszegi, N., & Leof, E. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23118 · Cited by 52
Wrans, J., & Pawson, T. J. (1997) · Nature · doi:10.1038/40290 · Cited by 52
BRAM1, a BMP receptor‐associated molecule involved in BMP signalling
Kurozumi, K., Nishita, M., Yamaguchi, T., Fujita, T., Ueno, N., & Shibuyà, H. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00186.x · Cited by 51
Holy Tolloido: Tolloid cleaves SOG/Chordin to free DPP/BMPs
Mullins, M. C. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01431-0 · Cited by 51
Ventura, F., Liu, F., Doody, J. F., & Massagué, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.13931 · Cited by 50
Spemann organizer activity of Smad10
LeSueur, J. A., & Graff, J. M. (1999) · Development · doi:10.1242/dev.126.1.137 · Cited by 49
Bützow, R. C., Fukushima, D., Twardzik, D. R., & Ruoslahti, E. I. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.3.721 · Cited by 44
Functional antagonism between activin and osteogenic protein-1 in human embryonal carcinoma cells
Piek, E., Afrakhte, M., Sampath, K. T., van Zoelen, E. J. J., Heldin, C., & ten Dijke, P. (1999) · Journal of Cellular Physiology · Cited by 43
Self-citationDrosophila dSmad2 and Atr‐I transmit activin/TGFβ signals
Das, P. K., Inoue, H., Baker, J. C., Beppu, H., Kawabata, M., Harland, R. M., Miyazono, K., & Padgett, R. W. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00244.x · Cited by 42
Mackay, K., & Danielpour, D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92904-2 · Cited by 40
Abraham, S., Carter, M. C., & Moran, E. M. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.6.655 · Cited by 31
Piek, E., Franzèn, P., Heldin, C., & ten Dijke, P. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199712)173:3<447::aid-jcp17>3.0.co;2-8 · Cited by 25
Self-citationShoji, H., Nakamura, T., Raaij, A. J. M. V. D. E.-V., & Sugino, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8613 · Cited by 23
Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process
Anglés‐Cano, E. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997001100002 · Cited by 21
ten Dijke, P., & Heldin, C. (1999) · Nature · doi:10.1038/16357 · Cited by 14
Self-citation
Cited by
Reactive oxygen species in cell signaling
Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,927
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
Metadata
- Authors
- PIEK, E., HELDIN, C., & DIJKE, P. T.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1999-12
- Volume
- 13
- Issue
- 15
- Pages
- 2105-2124
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W4296927411
- Cited by
- 656
- References
- 218
- FWCI
- 17.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.